Dr Tim Guilliams

CEO of Healx and Founding Director of CRDN

Tim is a social eguilliams-dr-timntrepreneur passionate about startups, technology transfer and knowledge exchange. As Founder & CEO of Healx, he is excited about the challenge of delivering the next generation of therapeutics to rare disease patients in need.

He is also the Founding Director of the Cambridge Rare Disease Network, a non-profit aiming to foster dialogue, awareness and bring together the active stakeholders in the rare disease space. Tim is equally a Junior Associate Fellow of the Centre for Science and Policy (CSaP) at Cambridge University.

Prior to Healx, Tim was the Director of Knowledge Exchange at Innovation Forum. He spent some time at the Department for Business, Innovation and Skills (BIS) working on University-Industry interactions and cluster dynamics in the area of Life Sciences. His PhD was obtained in the field of Biophysical Neuroscience at the University of Cambridge, where his research related to the development of camelid antibody fragments (Nanobodies) as potential therapeutic and biophysical tool for Parkinson’s disease.

Before moving to Cambridge, Tim obtained an MEng in Bio-Engineering from the University of Brussels (VUB).